Superworth

ResMed price to book ratio RMD

Market value divided by the book value of the company's net assets, since 2010.

Today, Oct 23, 2026
5.5×
10-year median
7.4×
Against its 10-year history
13th
percentile: 0 is its lowest day, 100 its highest
10-year range
4.2× to 14.9×
Peer median
3.0×

ResMed's price to book ratio is 5.5× as of Oct 23, 2026.

That is below its ten-year median of 7.4×, lower than on 87% of days in the last ten years.

Over that time it ranged from 4.2× in Jun 2026 to 14.9× in Sep 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 3.0×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far5.5×4.2×6.3×
20255.8×5.7×7.4×
20246.6×5.7×7.5×
20236.0×4.7×10.0×
20228.9×8.8×12.2×
202112.5×9.4×14.9×
202011.5×7.3×13.0×
201910.6×6.9×10.6×
20188.4×6.1×8.5×
20175.9×4.9×6.0×
20164.9×4.6×5.9×
20155.1×4.5×6.6×
20144.8×3.7×4.8×
20133.9×3.5×5.0×
20123.4×2.7×3.6×
20112.7×2.4×3.5×
20103.5×3.3×3.6×

Against its peers

Companies in Medical - Instruments & Supplies nearest ResMed's size, closest first, today.

CompanyPrice to book ratio
RMDResMed5.5×
MDLNMedlinen/m
WSTWest Pharmaceutical Services9.2×
BDXBecton, Dickinson and2.2×
SOLVSolventum3.0×
PENPenumbra8.3×
COOCooper Companies1.4×
ALGNAlign Technology2.6×
GMEDGlobus Medical2.3×
PODDInsulet7.3×
ISRGIntuitive Surgical9.9×
Peer median3.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on ResMed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.